Latest Capital Raises News

Riedel Resources Limited has progressed its Kingman Project in Arizona, securing $1.4 million in fresh capital to fund drilling and development activities at the high-grade Tintic deposit. The company also strengthened its board with the appointment of an experienced independent director.

Audalia Resources has completed critical drilling programs at its Medcalf vanadium-titanium-iron project, progressing resource upgrades and mine design while managing tight cash reserves and financing arrangements.

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Haranga Resources is poised to complete its acquisition of the Lincoln Gold Project in California, bolstered by strong due diligence results, while advancing uranium and gold exploration projects in Senegal with permit renewals and maiden drilling.

Lion Energy Limited reported a net cash outflow in Q2 2025 but maintains a solid cash position of AUD 2.13 million alongside a convertible note facility, signaling cautious optimism for its exploration activities.

Octava Minerals has secured a binding agreement to acquire the Federation Cu-Zn-Ag Project in Tasmania, reported promising bioleaching test results at its Byro REE-Li Project, and raised $1.5 million to fund exploration and working capital.

Rey Resources reports continued exploration progress in Western Australia's Canning Basin alongside a stable financial footing supported by substantial shareholder loans.

Tennant Minerals has identified a significant copper anomaly at its Bluebird East prospect, mirroring the high-grade Bluebird discovery, while advancing large-scale gold-copper targets at its Barkly Project in the Northern Territory.

Mount Burgess Mining advances metallurgical test work at its Nxuu deposit, navigates leadership changes, and pursues a significant legacy debt extinguishment as it refines its strategic focus.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 45 active trials worldwide and anticipates UK revenue by Q2 FY26 following successful supermarket partnerships.